期刊
CELLS TISSUES ORGANS
卷 185, 期 1-3, 页码 95-99出版社
KARGER
DOI: 10.1159/000101308
关键词
epithelial-mesenchymal transition; CCN; CCN6; WISP3; WISP; breast cancer; inflammatory breast cancer
资金
- NATIONAL CANCER INSTITUTE [R01CA077612, K08CA090876, R01CA107469] Funding Source: NIH RePORTER
- NCI NIH HHS [K08 CA090876, R01 CA107469, R01 CA77612] Funding Source: Medline
CCN6 (WISP3) is a cysteine-rich secreted protein that belongs to the CCN (Cyr61, CTGF, Nov) family of genes. We found that CCN6 mRNA is reduced in 80% of cases of the most lethal form of locally advanced breast cancer, inflammatory breast cancer. CCN6 contains four highly conserved motifs with sequence similarities to insulin-like growth factor binding proteins, von Willebrand type C, thrombospondin 1, and a carboxyl-terminal domain putatively involved in dimerization. CCN6 has tumor growth-, proliferation-, and invasion-inhibitory functions in breast cancer. Recently, by using a small infering RNA to downregulate CCN6 in immortalized human mammary epithelial cells, CCN6 was found to be essential to induce the process of epithelial-mesenchymal transition (EMT) with repression of E-cadherin gene expression and induction of a protein expression program characteristic of EMT. This review will focus on the current knowledge regarding the function of CCN6 in breast cancer with special emphasis on the emerging role of CCN6 as a regulator of the epithelial phenotype and E-cadherin expression in the breast. Copyright (c) 2007 S. Karger AG, Basel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据